Read article—Nicholas Jacobson, an associate professor of biomedical data and psychiatry, is quoted in a story about states’ legislation to regulate therapy chatbots. The story mentions Jacobson’s Therabot study and his recent op-ed and testimony about New Hampshire Senate Bill 640. “These systems need to be designed to mitigate the risks,” Jacobson said. “But at the same time there is a lot of promise here.”

Read article – Features a conversation with Christopher Sharp, MED ’98, about how AI is changing medicine and can be used to support patients and doctors. “AI provides an important window to access data locked up in narratives somewhere in the record that would be very hard to identify or find. It also provides the opportunity to utilize data in new ways that does not require as much effort by our clinicians,” Sharp said.

Read article – Steven Woloshin MED ’96, a professor of medicine and community and family medicine, is featured in an article about the debate over direct-to-consumer ads. “Part of aging is developing health conditions and becoming a target of drug advertising,” Woloshin said.

Read article—Marcus Shaker, a professor of pediatrics and medicine, provides a perspective on a new study into the cost profile of single maintenance and reliever therapy (SMART) compared with traditional asthma therapy. “A SMART approach to asthma is straightforward and easily understandable by clinicians and patients alike,” Shaker said.

Listen to story—Features Timothy Linn, an assistant professor of orthopedics and co-head team orthopedic surgeon of Dartmouth’s sports medicine department, in a Weekend Edition story about alpine skier Lindsey Vonn’s plans to compete in the women’s downhill race, Sunday, February 8. “She’s going to go side to side, but she’s not planting her foot and pivoting on it, hopefully,” Linn said. “You can engage your quads and hamstrings to stabilize the knee in a predictable way.”

Read article—Shelby Sullivan, a professor of medicine, is quoted in an article about the next wave of weight loss medication research. “The treatment difference we saw in this study, with Revita patients continuing to lose weight while sham patients rapidly regained weight, is striking. If these findings continue to hold with more data, duodenal mucosal resurfacing could represent a novel and much-needed solution to the largest gap in obesity care: post-GLP-1 weight maintenance,” Sullivan said.

Read article—Lynn Fiellin, a professor of biomedical data science, is featured in an article about a grant her play2PREVENT Lab received to develop a video game for young people on the autism spectrum. She also talks about the lab’s larger work designing games that teach adolescents and teens skills they can apply in life. “The beauty with [gaming] is that, since it’s interactive, they then, as the player, have the opportunity to do something … How do you learn to help a friend who is struggling and needs counseling? I mean, this is not something a 16-year-old necessarily knows,” Fiellin said.

Read article—Steve Woloshin, MD, professor of health policy and clinical science at Geisel, is quoted in an article about pharmaceutical advertising at the Super Bowl.

Listen to story—Megan Romano, an associate professor of epidemiology, is quoted in episode four of a series on PFAS contamination in New Hampshire municipal water supplies about how “forever chemicals” behave inside the body. “We think this is part of why PFAS seem to affect so many different aspects of health, because they are able to kind of hang out in the blood. And that allows them to reach many, many target organs and affect many different places in the body, as opposed to really congregating in one section or another,” Romano said.